IDEAYA Biosciences (IDYA) Shares Outstanding (2018 - 2026)

IDEAYA Biosciences has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $87.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.33% year-over-year to $87.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.9 million (changed 0.33% YoY) and the FY2025 annual result came in at $87.8 million, up 1.49% from the prior year.
• Shares Outstanding (Entity) held at $87.9 million in Q1 2026 per IDYA's latest filing, from $87.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $87.9 million in Q1 2026 and troughed at $38.6 million in Q1 2022.
• A 5-year average of $68.6 million and a median of $74.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) jumped 54.5% in 2024, then increased 0.33% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $48.2 million in 2022, then jumped by 34.96% to $65.0 million in 2023, then jumped by 33.0% to $86.5 million in 2024, then climbed by 1.49% to $87.8 million in 2025, then increased by 0.07% to $87.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $87.9 million, $87.8 million, and $87.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.